Results 251 to 260 of about 10,477,560 (323)
Olivia Newton-John Cancer Research Institute 10-year Anniversary Conference - a decade of discovery and translation. [PDF]
Eljammas K+7 more
europepmc +1 more source
Germline variants in CDKN2A wild‐type melanoma prone families
Among melanoma‐prone families, wild‐type for CDKN2A and CDK4, some have pathogenic variants in genes not usually linked to melanoma. Furthermore, rare XP‐related variants and variants in MC1R are enriched in such families. Germline pathogenic variants in CDKN2A are well established as an underlying cause of familial malignant melanoma. While pathogenic
Gjertrud T. Iversen+5 more
wiley +1 more source
Supportive Care Needs and Related Interventions in Patients with Pancreatic Cancer and Their Informal Caregivers: A Scoping Review. [PDF]
Fu L+9 more
europepmc +1 more source
Chronic TGF‐β exposure drives epithelial HCC cells from a senescent state to a TGF‐β resistant mesenchymal phenotype. This transition is characterized by the loss of Smad3‐mediated signaling, escape from senescence, enhanced invasiveness and metastatic potential, and upregulation of key resistance modulators such as MARK1 and GRM8, ultimately promoting
Minenur Kalyoncu+11 more
wiley +1 more source
Association of cancer with overactive bladder and impact of overactive bladder on mortality among cancer survivors: NHANES 1999-2018. [PDF]
Zhi B+5 more
europepmc +1 more source
Elements of cancer immunity and the cancer–immune set point
Daniel S. Chen, I. Mellman
semanticscholar +1 more source
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau+11 more
wiley +1 more source
A CRITICAL STUDY OF REGIONAL INTRA-ARTERIAL NITROGEN MUSTARD THERAPY IN CANCER
Charles D. Bonner+2 more
openalex +2 more sources